— Know what they know.
Not Investment Advice

OMCL NASDAQ

Omnicell, Inc.
1W: -0.1% 1M: +19.4% 3M: +8.7% YTD: -3.1% 1Y: +52.0% 3Y: -37.7% 5Y: -66.8%
$44.41
+0.65 (+1.49%)
 
Weekly Expected Move ±11.6%
$33 $38 $43 $48 $53
NASDAQ · Healthcare · Medical - Healthcare Information Services · Alpha Radar Strong Buy · Power 68 · $2.0B mcap · 44M float · 1.31% daily turnover · Short 71% of daily vol

Cash Flow Trends

Operating Cash Flow
$127M -32.2% ▼
5Y CAGR: -7.3%
Capital Expenditures
$40M -10.8% ▼
5Y CAGR: -5.9%
Free Cash Flow
$87M -42.6% ▼
5Y CAGR: -7.9%
Dividends Paid
$0 +0.0% ▲
Buybacks
$78M +0.0% ▲
Net Change in Cash
-$148M -44.2% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$78M$6M-$20M$13M$2M
Depreciation & Amort.$107M$99M$96M$90M$87M
Stock-Based Comp.$53M$68M$0$39M$45M
Change in Working Capital-$57M-$73M$44M$58M-$8M
Other Non-Cash Items$50M$15M$73M$3M$4M
Operating Cash Flow$232M$78M$181M$188M$127M
— Investing Activities —
Capital Expenditures-$29M-$61M-$55M-$36M-$40M
Acquisitions (Net)-$354M$2M$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0-$15M$0-$10M-$10M
Other Investing-$29M$15M$0-$6M-$10M
Investing Cash Flow-$412M-$59M-$55M-$53M-$60M
— Financing Activities —
Net Debt Issuance$0$0-$3M-$225M-$175M
Stock Repurchased-$16M-$52M$0$0-$78M
Dividends Paid$0$0$0$0$0
Other Financing$64M$31M$3M-$49M$17M
Financing Cash Flow$47M-$21M$23M-$236M-$218M
Net Change in Cash-$134M-$3M$148M-$102M-$148M
Cash End of Period$356M$353M$501M$399M$251M
Free Cash Flow$203M$17M$140M$151M$87M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms